The emerging role of checkpoint inhibitors for rare genitourinary cancers

被引：0
|
作者：
Aragon-Ching, Jeanny B. [1 ]
机构：
[1] Inova Schar Canc Inst, GU Med Oncol, Fairfax, VA 22031 USA
来源：
NATURE REVIEWS UROLOGY | 2021年 / 18卷 / 03期
关键词：
CARCINOMA;
D O I：
10.1038/s41585-021-00426-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Rare genitourinary cancers have historically been challenging to treat given the scarcity in incidence, inadequacy of data on treatment and lack of general consensus to guide routine therapy. A phase II multicentre trial shows efficacy of nivolumab and ipilimumab in several cohorts of patients with rare genitourinary cancers.
引用
收藏
页码：133 / 134
页数：2
相关论文
共 50 条
  • [1] The emerging role of checkpoint inhibitors for rare genitourinary cancers
    Jeanny B. Aragon-Ching
    [J]. Nature Reviews Urology, 2021, 18 : 133 - 134
  • [2] Safety of checkpoint inhibitors in older patients with genitourinary cancers
    Ramnaraign, Brian Hemendra
    Patel, Neil Jigish
    Chatzkel, Jonathan Alexander
    Hitchcock, Kathryn
    Zlotecki, Robert
    O'Malley, Padraic
    Crispen, Paul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Emerging role of immune checkpoint inhibitors and predictive biomarkers in head and neck cancers
    Elbehi, Attia M.
    Anu, R., I
    Ekine-Afolabi, Bene
    Cash, Elizabeth
    [J]. ORAL ONCOLOGY, 2020, 109
  • [4] Immune Checkpoint Inhibitors for Genitourinary Cancers: Treatment Indications, Investigational Approaches and Biomarkers
    Labadie, Brian W.
    Balar, Arjun V.
    Luke, Jason J.
    [J]. CANCERS, 2021, 13 (21)
  • [5] Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancers
    Karim, Frederic
    Amin, Adina
    Liu, Marie
    Vishnuvardhan, Nivetha
    Amin, Saif
    Shabbir, Raffey
    Swed, Brandon
    Khan, Uqba
    [J]. CANCERS, 2023, 15 (16)
  • [6] Emerging immune checkpoint inhibitors for the treatment of head and neck cancers
    Green, Sarah E.
    McCusker, Michael G.
    Mehra, Ranee
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2020, 25 (04) : 501 - 514
  • [7] Angiogenesis inhibitors in genitourinary cancers
    Walter, S
    Wilding, G
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2003, 46 : S41 - S47
  • [8] Characterizing patterns of disease progression in patients with genitourinary cancers treated with immune checkpoint inhibitors
    Patel, Vaibhav G.
    Qin, Qian
    Mellgard, George
    Parikh, Anish B.
    Wang, Bo
    Alerasool, Parissa
    Garcia, Philip
    Jaladanki, Suraj
    Leiter, Amanda
    Carroll, Emily
    Brooks, Danielle
    Ben Shimol, Jennifer
    Eisenberg, Elliot
    Gallagher, Emily J.
    Galsky, Matt D.
    Oh, William K.
    Tsao, Che-Kai
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [9] Safety, efficacy and prognostic impact of immune checkpoint inhibitors in older patients with genitourinary cancers
    Schulz, Gerald Bastian
    Rodler, Severin
    Szabados, Bernadett
    Graser, Annabel
    Buchner, Alexander
    Stief, Christian
    Casuscelli, Jozefina
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (07) : 1061 - 1066
  • [10] Immune checkpoint inhibitors in genitourinary malignancies
    Thana, M.
    Wood, L.
    [J]. CURRENT ONCOLOGY, 2020, 27 : S69 - S77
12345